MENU

LabReady sponsors Group B Strep Support virtual conference on June 2, 2021

Card image cap
Jun 02, 2021 · By Lenny
On Wednesday, June 2, 2021, Group B Strep Support (GBSS) is holding their one-day virtual conference, Group B Strep in Pregnancy & Babies. There will be multiple speakers at this event, including Carol J. Baker, Professor of Pediatrics at McGovern Medical School at the University of Texas and Sabin Gold Medal winner; Professor Androulla Efstratiou from the Imperial College in London and Director of WHO Global Collaborating Centre for Diptheria & Streptococcal Infections; and Professor Anne Mackie, Director of Screening for Public Health England. 

Conference chairs for this event are Edward Morris, President of the Royal College of Obstetricians and Gynaecologists and Chair of Trustees for GBSS; and Kathryn Gutteridge, President of the Royal College of Midwives and GBSS Trustee. 

Sponsorship Information

LabReady is proud to be a silver sponsor for this event, joining Pfizer, Cepheid, and Leigh Day. 

Group B Strep’s Impact

Group B Strep (GBS) is a leading cause of neonatal infection – including sepsis, pneumonia and meningitis – in the UK and worldwide. Illness and death caused by this bacteria can be prevented through testing and antibiotics. At this conference, experts from around the world come together to discuss GBS prevention through policy, testing and antibiotic usage as well as current progress toward a GBS vaccine. 

About LabReady

The first step in preventing illness or death caused by GBS is testing. LabReady has developed an improved specimen transport system for GBS samples as they travel from doctor to laboratory. These self-contained units regulate specimen temperature to maintain an unbroken cold chain and provide a nutritive solution to facilitate faster testing and diagnosis. 

To speak with a LabReady representative, email us: https://www.labready.com/#modalPatients.
Lenny

Leonard (Lenny) founded Vax-Immune in 2015 with a vision to innovate how we diagnose infectious diseases. As a neonatologist for 40 years, Lenny watched babies die due to misdiagnosis and after realizing that the problem lay in the way samples were being transported, “retired" to develop the first specimen transport system with specimen multiplier technology, eliminating the need for traditional transport and preventing misdiagnosis. The son of Holocaust survivors, Lenny was born in a displaced persons camp in Germany, came to America and went on to graduate from West Point. After completing Airborne, Ranger and Air Defense Artillery schools, he served 24 years in the Army as an academic neonatologist, where he discovered and developed the breakthrough drug for Medimmune, which sold to Astra Zeneca for $15B. After retiring from the Army, Lenny joined the faculty at Baylor College of Medicine where he served as the Chief, Newborn Service, Texas Children’s Hospital, where his vision to build a women’s hospital became the Women’s Pavilion. While at TCH, he spearheaded the birth and care of the world’s first surviving set of octuplets and was featured in The New York Times, CNN, Today Show and in the international media.

By navigating this website, you agree to our Cookie Policy
LabReady | Logo